By Benjamin Horney (February 14, 2019, 4:12 PM EST) -- The CEO of Nestle SA said during a conference call on Thursday that the company has received plenty of interest for its skin health business, which could be worth around $7 billion, according to a Thursday report from Reuters. According to the report, Mark Schneider, the top executive for Nestle, said "we've seen very, very strong interest in this process, and literally people lining up around the block to be part of this process." First-round bids for the business, which sells products under brands including Cetaphil and Proactiv, are due March 6, the report said. Private equity firms Cinven and Advent International are rumored to be partnering on a proposal, and "several other firms" are also expected to make offers....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
